The production volumes of chemical and pharmaceutical products in France have shown varied trends over the past decade, with notable fluctuations from 2013 to 2023. Despite a significant dip in 2020, attributed to the global pandemic, a remarkable recovery occurred in 2021 with a 33.85% year-on-year increase. From 2013 to 2023, the Compound Annual Growth Rate (CAGR) reflects moderate growth and recovery periods, culminating in a value of 99.55 billion euros in 2023.
Year-on-year variations typically highlight the immediate annual changes, with significant fluctuations such as the 16.42% decline in 2020 and 33.85% surge in 2021. Over the last two years (2022-2023), the trend was stable with a slight increment. The five-year CAGR provides an average annual growth rate, crucial for understanding long-term performance and potential future trends.
Looking ahead, an optimistic forecast predicts continuous growth, albeit at a moderate pace, with an expected CAGR of 0.72% from 2024 to 2028 and an overall growth rate of 3.65%. This points to steady yet incremental advancements in production volumes, reaching 104.96 billion euros by 2028.
Future trends to watch for:
- Impact of technological advancements and automation in manufacturing processes.
- Potential regulatory changes within the EU affecting the pharmaceutical sector.
- Global economic shifts and their influence on production and export capabilities.
- Expansion of innovative pharmaceuticals and sustainable chemical production.
